RYSPX
Price
$94.75
Change
+$0.29 (+0.31%)
Updated
Jul 16 closing price
Net Assets
164.14M
VTSMX
Price
$149.57
Change
+$0.58 (+0.39%)
Updated
Jul 16 closing price
Net Assets
1.91T
Interact to see
Advertisement

RYSPX vs VTSMX

Header iconRYSPX vs VTSMX Comparison
Open Charts RYSPX vs VTSMXBanner chart's image
Rydex S&P 500 H
Price$94.75
Change+$0.29 (+0.31%)
VolumeN/A
Net Assets164.14M
Vanguard Total Stock Mkt Idx I
Price$149.57
Change+$0.58 (+0.39%)
VolumeN/A
Net Assets1.91T
RYSPX vs VTSMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RYSPX vs. VTSMX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYSPX is a Buy and VTSMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.91T vs. RYSPX (164M). VTSMX pays higher dividends than RYSPX: VTSMX (1.12) vs RYSPX (0.14). RYSPX was incepted earlier than VTSMX: RYSPX (19 years) vs VTSMX (33 years). RYSPX (1.65) is less costly to investors than VTSMX (0.14). RYSPX is a more actively managed with annual turnover of: 137.00 vs. VTSMX (2.00). RYSPX has a lower initial minimum investment than VTSMX: RYSPX (2500) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 9.80 vs. RYSPX (8.81). VTSMX return over 5 years is better than : 88.36 vs. RYSPX (62.83).
RYSPXVTSMXRYSPX / VTSMX
Total Expense Ratio1.620.141,157%
Annual Report Gross Expense Ratio1.650.141,179%
Fund Existence19 years33 years-
Gain YTD5.9565.711104%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets164M1.91T0%
Annual Yield % from dividends0.141.1213%
Returns for 1 year8.819.8090%
Returns for 3 years56.6959.4095%
Returns for 5 years62.8388.3671%
Returns for 10 years123.19188.7665%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APAM46.380.97
+2.14%
Artisan Partners Asset Management
PWP19.210.09
+0.47%
Perella Weinberg Partners
BAX28.370.12
+0.42%
Baxter International
ZENV1.42-0.05
-3.40%
Zenvia
KZIA10.19-0.61
-5.65%
Kazia Therapeutics Limited